CONCORD DRUGS
Back to Cashflow Statement
|
CONCORD DRUGS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-0.02 Cr | ₹0.07 Cr | ₹0.02 Cr | ₹0.01 Cr |
What is the latest Net Cash Inflow / Outflow ratio of CONCORD DRUGS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-0.02 Cr |
| Mar2024 | ₹0.07 Cr |
| Mar2023 | ₹0.02 Cr |
| Mar2022 | ₹0.01 Cr |
How is Net Cash Inflow / Outflow of CONCORD DRUGS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.02 Cr | Negative | |
| Mar2024 | ₹0.07 Cr | 204.55 | |
| Mar2023 | ₹0.02 Cr | 144.44 | |
| Mar2022 | ₹0.01 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of CONCORD DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD DRUGS | ₹96.0 Cr | 8.3% | 2% | 6.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
CONCORD DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD DRUGS | 8.3% |
2% |
6.2% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses